TejaswiniKulkarniMD

Pulmonology • Birmingham, AL

Critical Care Medicine, Interstitial Lung Diseases, Occupational & Environmental Lung Disease

Physician

Join to view full profile

Dr. Kulkarni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kulkarni's full profile

Already have an account?

Office
THT 422
1900 University Blvd
Birmingham, AL 35294
Phone+1 205-996-7174
Is this information wrong?

Education & Training

University of Alabama Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2016
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2010 - 2013
Bangalore Medical CollegeClass of 2008

Certifications & Licensure

AL State Medical License 2013 - 2024
MI State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis Start of enrollment: 2023 May 15
Recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;BMC Pulmonary Medicine. 2024 Mar 20
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
Leticia Kawano-Dourado, Tejaswini Kulkarni, Christopher J Ryerson, Pilar Rivera-Ortega, Bruno Guedes Baldi, Nazia Chaudhuri, Manuela Funke-Chambour, Anna-Maria Hoffman...> ;Thorax. 2024 Mar 6
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;Research Square. 2024 Feb 28
Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis.
Bodduluri, S., O'Hare, L., Blumhoff, S., Acosta Lara, M., de Andrade, J., Kim, Y., McDonald, M., Sridhar, M., Luckhardt, T., Kulkarni, T.> ;Respiratory Research. 2024 Feb 8
Pulmonary Surface Irregularity Score as a New Quantitative CT Marker for Idiopathic Pulmonary Fibrosis-a Pilot Study.
Asser M Abou Elkassem, Rafah Mresh, Ahmed Farag, Steven Rothenberg, Seth T Lirette, Andrew D Smith, Tejaswini Kulkarni> ;Journal of Digital Imaging. 2023 Dec 1
Evaluating the consistency with guideline recommendations for diagnosis and management of idiopathic pulmonary fibrosis in non-academic settings.
Joao De Andrade, Tracy Luckhardt, Sushilkumar Sonavane, D Ralph Crowe, Tejaswini Kulkarni, Maria Del Pilar Acosta Lara, Swati Gulati, Young Il-Kim, Rekha Ramachandran,...> ;Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2023 Mar 28
2 citations
Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases.
Kevin G Dsouza, Ranu Surolia, Tejaswini Kulkarni, Fu Jun Li, Pooja Singh, Huaxiu Zeng, Crystal Stephens, Abhishek Kumar, Zheng Wang, Veena B Antony> ;Respiratory Research. 2023 Mar 28
1 citations
Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease.
Kevin G Dsouza, Amanda S Alexander, Jubal R Watts Jr, Tejaswini Kulkarni> ;Multidisciplinary Respiratory Medicine. 2023 Jan 17
Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
Joao A de Andrade, Tejaswini Kulkarni, Megan L Neely, Anne S Hellkamp, Amy Hajari Case, Daniel A Culver, Kalpalatha Guntupalli, Shaun Bender, Craig S Conoscenti, Lauri...> ;Respiratory Research. 2022 Jan 7
Editorial: Fibrotic Lung Disease-"Lumping" the Progressive Phenotype.
Tejaswini Kulkarni, Sydney B Montesi, Bridget F Collins> ;Frontiers in Medicine. 2022 Jan 1
8 citations
Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations.
Tejaswini Kulkarni, Vincent G. Valentine, Fei Fei, Thi K. Tran-Nguyen, Luisa D Quesada-Arias, Takudzwa Mkorombindo, Huy P. Pham, Sierra C. Simmons, K.G. Dsouza, Tracy ...> ;Plos One. 2021 Nov 23
3 citations
Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry.
Joao A. de Andrade, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case, Kalpalatha K. Guntupalli, Shaun Bender, Craig S Conoscenti, Laurie D. Snyder...> ;Respiratory Medicine. 2021 Sep 29
3 citations
Top Ten Tips Palliative Care Clinicians Should Know About Prognostication in Oncology, Dementia, Frailty, and Pulmonary Diseases
Mathias Schlögl, Anand S Iyer, Florian Riese, David Blum, Lanier O'Hare, Tejaswini Kulkarni, Sophie Pautex, Jan Schildmann, Keith M. Swetz, Pallavi Kumar, Christopher ...> ;Journal of Palliative Medicine. 2021 Jul 14
57 citations
Citrullinated vimentin mediates development and progression of lung fibrosis
Fu Jun Li, Ranu Surolia, Huashi Li, Zheng Wang, Gang Liu, Tejaswini Kulkarni, Adriana V.F. Massicano, James A. Mobley, Santanu Mondal, Joao A. de Andrade, Scott A. Coo...> ;Science Translational Medicine. 2021 Mar 17
248 citations
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomise...
Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim A. Wuyts, Susanne Stowasser, Manuel Qu...> ;The Lancet. Respiratory Medicine. 2020 May 1
37 citations
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu> ;JCI Insight. 2020 Mar 12
10 citations
The senescence-associated matricellular protein CCN1 in plasma of human subjects with idiopathic pulmonary fibrosis.
Tejaswini Kulkarni, Ashish Kurundkar, Young-il Kim, Joao A. de Andrade, Tracy Luckhardt, Victor J. Thannickal> ;Respiratory Medicine. 2020 Jan 1
5 citations
Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treat.
Tejaswini Kulkarni, Steven R. Duncan> ;Current Pulmonology Reports. 2019 Nov 26
27 citations
Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.
Tejaswini Kulkarni, Kaiyu Yuan, Thi K. Tran-Nguyen, Young-il Kim, Joao A. de Andrade, Tracy Luckhardt, Vincent G. Valentine, Daniel J. Kass, Steven R. Duncan> ;Plos One. 2019 Oct 4
12 citations
Update in Pulmonary Fibrosis 2018.
Giacomo Sgalla, Tejaswini Kulkarni, Danielle Antin-Ozerkis, Victor J. Thannickal, Luca Richeldi> ;American Journal of Respiratory and Critical Care Medicine. 2019 Aug 1
70 citations
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
Camille M. Moore, Rachel Z. Blumhagen, Ivana V. Yang, Avram D Walts, Julie Powers, Tarik Walker, Makenna Bishop, Pamela Russell, Brian Vestal, Jonathan Cardwell, Chery...> ;American Journal of Respiratory and Critical Care Medicine. 2019 Jul 15
27 citations
Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
Jarrod W. Barnes, Dawn Duncan, Scott Helton, Samuel B. Hutcheson, Deepali Kurundkar, Naomi J. Logsdon, Morgan L. Locy, Jaleesa M. Garth, R. Denson, Carol Farver, Hai T...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2019 May 1
11 citations
Preoperative Evaluation of Patients With Interstitial Lung Disease.
Nina Patel, Tejaswini Kulkarni, Daniel F. Dilling, Mary Beth Scholand, Interstitial> ;Chest. 2019 Jun 29
65 citations
Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis.
Fu Jun Li, Ranu Surolia, Huashi Li, Zheng Wang, Tejaswini Kulkarni, Gang Liu, Joao A. de Andrade, Daniel J. Kass, Victor J. Thannickal, Steven R. Duncan, Veena B. Antony> ;Journal of Immunology. 2017 Jul 28
16 citations
Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections
Ranu Surolia, Suman Karki, Zheng Wang, Tejaswini Kulkarni, Fu Jun Li, Shikhar Vohra, Hitesh Batra, Jerry A. Nick, Steven R. Duncan, Victor J. Thannickal, Adrie J. C. S...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2016 Sep 30
Join now to see all

Authored Content

An Update in Progressive Pulmonary FibrosisOctober 2022

Press Mentions

Pulmonary and Primary Care Experts Share Clinician Toolkit on Rare Disease Day to Raise Awareness for Interstitial Lung DiseaseFebruary 28th, 2023
Pulmonary and Primary Care Experts Share Research on Delays to Diagnosis in Complex Lung DiseasesSeptember 19th, 2022
Autoantibody Reduction Regimen Improves Lungs, Survival: StudyDecember 14th, 2021
Join now to see all

Hospital Affiliations

University of Alabama HospitalBirmingham, Alabama